Fosun Tourism’s post-Covid holiday fizzles
The resort unit of one of China’s leading conglomerates posted modest growth in the first quarter, as its broader outlook was clouded by debt issues at its parent Key Takeaways:…
CHINA BULLETIN: PMI Readings Signal Strong End to 2023
In this week’s issue New Year’s travel bounces back, Wanda sells off shopping malls and a top influencer topples a CEO. On a scale of 1 to 100, we give…
Fosun Tourism embarks on new journey with departure of big-name director
Henri Giscard d’Estaing has left the board of Fosun Tourism, which is refocusing on China and Southeast Asia, to ‘devote additional time and attention’ to his role leading Club Med…
Atour glides as economic slowdown fails to dent Chinese travel demand
The mid- to upscale hotel brand’s revenue rose 93% in the third quarter, as nearly all of its major metrics exceeded pre-pandemic levels Key Takeaways: Atour’s revenue nearly doubled and…
Tongcheng flies high on post-Covid domestic travel boom
Domestic tourism is one of the few bright spots in a Chinese economy beset with deflationary pressures, making a winner of China’s second largest online travel agent Key Takeaways: Tongcheng’s…
Fosun Tourism rides Club Med rebound into bumper profits
The global resort operator’s business volume rose 24% in the first half of the year, while its profit more than doubled Key Takeaways: Fosun Tourism’s business volume rose 24% in…
Atour shines on tourism rebound, but ‘revenge travel’ likely to be fleeting
The hotel operator’s revenue per available room (revpar) rose above pre-pandemic levels in the first quarter, but the figure is likely to soften through the rest of the year Key…
Recent Articles
RELATED ARTICLES
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK -
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism rides Club Med rebound into bumper profits
1992.HK
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
- CHINA BULLETIN: Next Stop, Deflation
-
Tongcheng flies high on post-Covid domestic travel boom
0780.HK
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
